Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset

[1]  P. Kirchhof,et al.  Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation , 2019, European heart journal.

[2]  H. Marques,et al.  Development and validation of a risk score for predicting atrial fibrillation recurrence after a first catheter ablation procedure - ATLAS score. , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  I. V. Van Gelder,et al.  Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction , 2018, European heart journal.

[4]  Jay A. Montgomery,et al.  Multi-ethnic genome-wide association study for atrial fibrillation , 2018, Nature Genetics.

[5]  Paulus Kirchhof,et al.  The future of atrial fibrillation management: integrated care and stratified therapy , 2017, The Lancet.

[6]  L. Mont,et al.  Diagnosis, pathophysiology, and management of exercise-induced arrhythmias , 2017, Nature Reviews Cardiology.

[7]  K. Clément,et al.  Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria , 2017, Proceedings of the National Academy of Sciences.

[8]  Ulrich Schotten,et al.  2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. , 2017, Revista espanola de cardiologia.

[9]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  A. Camm,et al.  Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary , 2016, European heart journal.

[11]  Parminder Raina,et al.  Maelstrom Research guidelines for rigorous retrospective data harmonization , 2016, International journal of epidemiology.

[12]  S. Yusuf,et al.  The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study , 2016, The Lancet.

[13]  H. Crijns,et al.  Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment , 2016, Nature Reviews Cardiology.

[14]  Claes Held,et al.  The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation , 2016, European heart journal.

[15]  A. Camm,et al.  XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation , 2015, European heart journal.

[16]  Ewout W Steyerberg,et al.  The number of subjects per variable required in linear regression analyses. , 2015, Journal of clinical epidemiology.

[17]  Christopher X. Wong,et al.  Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). , 2015, Journal of the American College of Cardiology.

[18]  K. Clément,et al.  Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. , 2015, European heart journal.

[19]  Tim Geach.  Atrial fibrillation: FGF-23 associated with incident AF—a link with CKD? , 2014, Nature Reviews Cardiology.

[20]  M. Zoni-Berisso,et al.  Epidemiology of atrial fibrillation: European perspective , 2014, Clinical epidemiology.

[21]  Stanley Nattel,et al.  Early management of atrial fibrillation to prevent cardiovascular complications. , 2014, European heart journal.

[22]  Jay A. Montgomery,et al.  The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation , 2014, Clinical Research in Cardiology.

[23]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[24]  D. Atar,et al.  High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. , 2014, Journal of the American College of Cardiology.

[25]  Matthieu Resche-Rigon,et al.  Multiple imputation for handling systematically missing confounders in meta‐analysis of individual participant data , 2013, Statistics in medicine.

[26]  D. Singer,et al.  Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. , 2013, The American journal of cardiology.

[27]  M. O'Neill,et al.  Catheter ablation of atrial fibrillation in heart failure. , 2013, Heart failure clinics.

[28]  Albert Hofman,et al.  Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. , 2013, European heart journal.

[29]  G. Breithardt,et al.  Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial , 2012, The Lancet.

[30]  M. Baneshi,et al.  Assessment of Internal Validity of Prognostic Models through Bootstrapping and Multiple Imputation of Missing Data , 2012, Iranian journal of public health.

[31]  D. Fliser,et al.  The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. , 2011, European heart journal.

[32]  Prashanthan Sanders,et al.  Pericardial fat is associated with atrial fibrillation severity and ablation outcome. , 2011, Journal of the American College of Cardiology.

[33]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[34]  Robby Nieuwlaat,et al.  Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. , 2010, Journal of the American College of Cardiology.

[35]  S. Connolly,et al.  Effect of dronedarone on cardiovascular events in atrial fibrillation. , 2009, The New England journal of medicine.

[36]  B. Knight,et al.  Approaches to catheter ablation of persistent atrial fibrillation. , 2009, Heart rhythm.

[37]  Todd E. Bodner,et al.  What Improves with Increased Missing Data Imputations? , 2008 .

[38]  Patrick Royston,et al.  How should variable selection be performed with multiply imputed data? , 2008, Statistics in medicine.

[39]  David Tamborero,et al.  Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. , 2007, European heart journal.

[40]  Charles E McCulloch,et al.  Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.

[41]  A. Hofman,et al.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.

[42]  G. Breithardt,et al.  Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial. , 2005, American heart journal.

[43]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[44]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[45]  G. Baxter.  The natriuretic peptides , 2004, Basic Research in Cardiology.

[46]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[47]  M. Rich,et al.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.

[48]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[49]  M. Enriquez-Sarano,et al.  Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. , 2000, Journal of the American College of Cardiology.

[50]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[51]  J. Concato,et al.  A simulation study of the number of events per variable in logistic regression analysis. , 1996, Journal of clinical epidemiology.

[52]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[53]  M. Arakawa,et al.  Alternations in atrial natriuretic peptide release after DC cardioversion of non-valvular chronic atrial fibrillation. , 1995, European heart journal.

[54]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[55]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[56]  S. Green.  How Many Subjects Does It Take To Do A Regression Analysis. , 1991, Multivariate behavioral research.

[57]  D. Altman,et al.  Bootstrap investigation of the stability of a Cox regression model. , 1989, Statistics in medicine.

[58]  A. Belanger,et al.  The Framingham study. , 1976, British medical journal.

[59]  P. Leprince,et al.  Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria , 2017, European heart journal.

[60]  P. Kirchhof,et al.  Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. , 2011, Physiological reviews.

[61]  David O. Martin,et al.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.

[62]  D. Tamborero,et al.  Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[63]  Willi Sauerbrei,et al.  The Use of Resampling Methods to Simplify Regression Models in Medical Statistics , 1999 .